These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22272726)

  • 21. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
    Hagiwara K; Hara H; Hanada K
    J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains.
    Caughey B
    Br Med Bull; 2003; 66():109-20. PubMed ID: 14522853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the cellular prion protein on amyloid-β and 3PO-tau processing.
    Schmitz M; Wulf K; Signore SC; Schulz-Schaeffer WJ; Kermer P; Bähr M; Wouters FS; Zafar S; Zerr I
    J Alzheimers Dis; 2014; 38(3):551-65. PubMed ID: 24028865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep.
    Lim K; Kim SY; Lee B; Segarra C; Kang S; Ju Y; Schmerr MJ; Coste J; Kim SY; Yokoyama T; An SS
    Int J Nanomedicine; 2015; 10(Spec Iss):241-50. PubMed ID: 26425091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spectrum of transmissible spongiform encephalopathies.
    Weber T; Aguzzi A
    Intervirology; 1997; 40(2-3):198-212. PubMed ID: 9450236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular prion protein neuroprotective function: implications in prion diseases.
    Roucou X; LeBlanc AC
    J Mol Med (Berl); 2005 Jan; 83(1):3-11. PubMed ID: 15645198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strain-specific effects of reducing agents on the cell-free conversion of recombinant prion protein into a protease-resistant form.
    Imamura M; Kato N; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T
    Microbiol Immunol; 2011 Sep; 55(9):633-40. PubMed ID: 21645053
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Meyerett-Reid C; Wyckoff AC; Spraker T; Pulford B; Bender H; Zabel MD
    mSphere; 2017; 2(1):. PubMed ID: 28144628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prions and their biology].
    Gasset M; Westaway D
    Rev Neurol; 2000 Jul 16-31; 31(2):129-32. PubMed ID: 10951668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental approaches to TSE prevention via inhibition of prion formation.
    Politopoulou G
    Protein Pept Lett; 2004 Jun; 11(3):249-55. PubMed ID: 15182226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.
    Capellari S; Parchi P; Russo CM; Sanford J; Sy MS; Gambetti P; Petersen RB
    Am J Pathol; 2000 Aug; 157(2):613-22. PubMed ID: 10934164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggregation of cellular prion protein is initiated by proximity-induced dimerization.
    Goggin K; Bissonnette C; Grenier C; Volkov L; Roucou X
    J Neurochem; 2007 Aug; 102(4):1195-205. PubMed ID: 17663754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurochemical nature of PrP(c)-containing cells in the rat brain.
    Moleres FJ; Velayos JL
    Brain Res; 2007 Oct; 1174():143-51. PubMed ID: 17854776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitin-specific protease 14 modulates degradation of cellular prion protein.
    Homma T; Ishibashi D; Nakagaki T; Fuse T; Mori T; Satoh K; Atarashi R; Nishida N
    Sci Rep; 2015 Jun; 5():11028. PubMed ID: 26061634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions.
    Rehders D; Claasen B; Redecke L; Buschke A; Reibe C; Jehmlich N; von Bergen M; Betzel C; Meyer B
    J Mol Biol; 2009 Sep; 392(1):198-207. PubMed ID: 19607841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.